The global cervical cancer diagnostic market size was valued at USD 4.5 billion in 2022 and is projected to reach USD 7.0 billion by 2030, expanding at a CAGR of 5.7% from 2023 to 2030. The market growth is primarily fueled by the rising prevalence of cervical cancer among middle-aged women and the growing demand for effective screening and diagnostic tests that enable early detection and...